Skip to main content

Find Clinical Trials

Home
Conditions
Neuroectodermal Tumors

Clinical trial condition

Neuroectodermal Tumors

Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.

6,006 public trials 1,218 recruiting studies

Refine in advanced search Browse all conditions

Neuroectodermal Tumors trial results

Completed

Impact of Excision Margins on Survival and Recurrence Rate in Patients With Thick Melanoma (>2mm)

NCT02088762

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Department of Dermatology Bern, Switzerland

View Trial Details

Completed

RAD001 With Paclitaxel and Carboplatin in First Line Treatment of Patients With Advanced Large Cell Lung Cancer With Neuroendocrine Differentiation

NCT01317615

Conditions: Carcinoma, Carcinoma, Large Cell, Lung Diseases, +12 more
Locations: Novartis Investigative Site Berlin, Germany

Novartis Investigative Site Bremen, Germany

Novartis Investigative Site Cologne, Germany

Novartis Investigative Site Essen, Germany

View Trial Details

Completed

68Ga-DOTATATE PET Scan in Neuroendocrine Cancer

NCT01396382

Conditions: Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +19 more
Locations: Vanderbilt University Medical Center Nashville, Tennessee, United States

View Trial Details

Completed

A Randomized Phase II Trial of Vandetanib (ZD6474) in Combination With Carboplatin Versus Carboplatin Alone Followed by Vandetanib Alone in Adults With Recurrent High-Grade Gliomas

NCT00995007

Conditions: Anaplastic Astrocytoma, Anaplastic Mixed Oligoastrocytoma, Anaplastic Oligodendroglioma, +24 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Comparison of In-House Methods and Cobas BRAF V600 Mutation Assay in Melanoma Tumor Samples

NCT01744860

Conditions: Malignant Melanoma, Melanoma, Neoplasms, +10 more
Locations: Boulogne-Billancourt, France

Colmar, France

Lille, France

Lyon, France

View Trial Details

Completed

Lapatinib Study for Children and Adults With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors

NCT00973739

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, Cranial Nerve Neoplasms, +28 more
Locations: New York University School of Medicine New York, United States

View Trial Details

Completed

Bevacizumab With or Without Interferon Alfa in Treating Patients With Metastatic Malignant Melanoma

NCT00026221

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +11 more
Locations: University of Cincinnati Cincinnati, Ohio, United States

Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Completed

A Study of Avastin (Bevacizumab) And Fotemustine in Patients With Recurrent Glioblastoma

NCT01474239

Conditions: Astrocytoma, Glioblastoma, Glioblastoma Multiforme, +8 more
Locations: San Giovanni Rotondo, Apulia, Italy

Naples, Campania, Italy

Bologna, Emilia-Romagna, Italy

Rome, Lazio, Italy

View Trial Details

Completed

Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell Transplant

NCT00293384

Conditions: Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +112 more
Locations: Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States

View Trial Details

Completed

Comparison of AZD6244 in Combination With Dacarbazine Versus (vs) Dacarbazine Alone in BRAF Mutation Positive Melanoma Patients

NCT00936221

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Research Site Aurora, Colorado, United States

Research Site Boston, Massachusetts, United States

Research Site Belo Horizonte, Brazil

Research Site Ijuí, Brazil

View all 38 locations

View Trial Details